We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Musculoskeletal Outcomes After Bone Marrow Transplant

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00558948
First Posted: November 16, 2007
Last Update Posted: August 19, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sidney Kimmel Comprehensive Cancer Center
November 14, 2007
November 16, 2007
August 19, 2009
May 2007
August 2009   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00558948 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Musculoskeletal Outcomes After Bone Marrow Transplant
Musculoskeletal Outcomes After Bone Marrow Transplant
The purpose of the study is to evaluate bone mineral density and muscle strength in survivors of bone marrow transplant. Association with age, type of transplant, steroids, years since transplant, body composition, endocrinopathies, radiation, quality of life and physical activity will be explored.
Bone marrow transplant survivors are at risk of diminished bone mineral density. Mechanisms and risks are not well understood. This study will help identify risks factors for developing this complication.
Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Survivors of bone marrow transplant (autologous and allogeneic) who are at least 1 year from transplant.
  • Survivors of Bone Marrow Transplant
  • Autologous and Allogeneic
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
48
August 2009
August 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Ages 8-30 years
  • One year from transplant

Exclusion Criteria:

  • No current steroid use
  • Medical conditions that would prohibit testing
  • Neuropsychological conditions that prohibit completing questionnaires
Sexes Eligible for Study: All
8 Years to 30 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00558948
J06120
1F31NR010038-01 ( U.S. NIH Grant/Contract )
Yes
Not Provided
Not Provided
Kathy Ruble, PhDc, RN, SKCCC
Sidney Kimmel Comprehensive Cancer Center
Not Provided
Study Director: Kathy Ruble, PhDc, RN Johns Hopkins University, School of Nursing
Sidney Kimmel Comprehensive Cancer Center
August 2009